STANLEY J. MERESMAN - 10 Sep 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Stanley J Meresman
Issuer symbol
GH
Transactions as of
10 Sep 2021
Net transactions value
-$611,023
Form type
4
Filing time
14 Sep 2021, 17:07:32 UTC
Previous filing
30 Aug 2021
Next filing
13 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $29,308 +4,934 +122% $5.94* 8,993 10 Sep 2021 Direct
transaction GH COMMON STOCK Sale $394,654 -3,052 -34% $129.31 5,941 10 Sep 2021 Direct F1, F2
transaction GH COMMON STOCK Sale $140,781 -1,082 -18% $130.11 4,859 10 Sep 2021 Direct F1, F3
transaction GH COMMON STOCK Sale $104,896 -800 -16% $131.12 4,059 10 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Options Exercise $0 -4,934 -11% $0.000000 39,473 10 Sep 2021 COMMON STOCK 4,934 $5.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.85 to $129.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.86 to $130.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.